Syndax Pharmaceuticals Form 4 Filed by Dennis Podlesak
A Form 4 for Syndax Pharmaceuticals was filed by Dennis Podlesak for Oct. 29.
Related stories
Microsoft Says Consumer Products Services Recovered
Microsoft said its consumer products services had fully recovered, while Microsoft 365 enterprise services were seeing a sustained recovery.
M impact | EQUITY | Nov 14, 2026, 05:17 AM UTC
Microsoft restores consumer product services after outage
Microsoft said its consumer product services have been restored; other services are not included in the update.
M impact | EQUITY | Nov 14, 2026, 05:10 AM UTC
Microsoft Outlook Begins Returning After Global Microsoft 365 Disruption
Microsoft said it was working to restore email access after a global Microsoft 365 disruption. Industry executives warned of risks from dependence on a single technology provider.
M impact | EQUITY | Nov 14, 2026, 04:31 AM UTC
Tesla sells Cybercab to first private customers
Reuters reports Tesla is offering its Cybercab to its first private customers.
M impact | EQUITY | Nov 14, 2026, 04:23 AM UTC
Microsoft says affected services fully recovered
L impact | EQUITY | Nov 14, 2026, 04:14 AM UTC
Eicher Motors Q2 Net Profit Rises 15% but Misses Estimates
Second-quarter consolidated net profit rose 15% year on year to 1,573 crore, below analysts’ estimates. Rising raw-material costs offset gains from strong motorcycle sales.
M impact | EQUITY | Nov 14, 2026, 04:12 AM UTC